Search clinical trials for: denagliptin (GW823093)
Total 206 results
-
GlaxoSmithKlineWithdrawnType 2 Diabetes MellitusUnited States
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Canada, Sweden, Latvia, Finland, Greece, Romania, Czechia, Puerto Rico
-
GlaxoSmithKlineTerminated
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPost-Traumatic Stress DisorderUnited States
-
GlaxoSmithKlineTerminatedDepressive DisorderUnited States, Canada
-
GlaxoSmithKlineTerminatedDepressive Disorder, MajorUnited States, Canada
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Boehringer IngelheimCompleted
-
Dong Wha Pharmaceutical Co. Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Genuine Research Center, EgyptEva PharmaCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Estonia, Germany, Latvia, Spain, United Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Universidad de GuanajuatoHospital Regional de Alta Especialidad del BajioUnknownInsulin Resistance | Prediabetic StateMexico
-
Boehringer IngelheimCompleted
-
Boryung Pharmaceutical Co., LtdCompletedHypertension | DiabetesKorea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Bangladesh, Belgium, Canada, China, Germany, Guatemala, Hong Kong, India, Lebanon, Mexico, Peru, Philippines, Spain, Taiwan
-
Evidem Consultores SLBoehringer Ingelheim; Merck Serono International SA; European CommissionUnknown
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Canada, Croatia, Estonia, France, Germany, India, Lithuania, Mexico, Netherlands, Romania, Russian Federation, Sweden, Tunisia, Ukraine
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Belgium, Canada, France, India, Italy, Korea, Republic of, Malaysia, Netherlands, Spain
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Brazil, Canada, El Salvador, France, Korea, Republic of, New Zealand, Norway, Spain, Taiwan
-
Boehringer IngelheimCompleted
-
GlaxoSmithKlineCompletedDepressive DisorderGermany
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Boryung Pharmaceutical Co., LtdCompleted
-
Boehringer IngelheimCompleted
-
JW PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Universidad de GuanajuatoHospital Regional de Alta Especialidad del BajioCompletedTransplanted Kidney Complication
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Taiwan, Philippines, Australia, Hong Kong, Korea, Republic of, Canada, Italy, Malaysia, United Kingdom, Mexico, Greece, Spain, Netherlands, Switzerland, Israel, Portugal, Germany, Finland, Norway, Romania, Sweden, Serbia and more
-
The Affiliated Hospital of Qingdao UniversityCompleted
-
Rabin Medical CenterUnknown
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Czech Republic, Finland, Greece, India, Israel, Mexico, New Zealand, Russian Federation, Sweden
-
Korea University Anam HospitalCompletedDiabetes MellitusKorea, Republic of
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Argentina, Belgium, Canada, China, Germany, Korea, Republic of, Philippines, Russian Federation, Taiwan, Turkey, United Kingdom
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Croatia, India, Israel, Italy, Malaysia, Netherlands, Poland, Romania, Slovakia, Thailand, Ukraine
-
Emory UniversityBoston Medical Center; Rush University; University of DenverCompleted
-
Jiangsu HengRui Medicine Co., Ltd.UnknownDiabetes Mellitus, Type II
-
BiogenCompletedAcute Ischemic StrokeSpain, United States, Germany
-
Fayoum UniversityBoehringer IngelheimCompletedDiabetes | Microalbuminuria | Kidney Function Affection Upon Exposure to RadiocontrastEgypt
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany, Spain, United States, Canada, Taiwan, Korea, Republic of, Finland, Denmark, France, Japan, Philippines, Vietnam